TrialDiabetologia2025

Dapagliflozin's impact on hormonal regulation and ketogenesis in type 1 diabetes: a randomised controlled crossover trial.

Andreas Gübeli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.